First- and second-line treatments for locally advanced renal cell carcinoma | EXEL Message Board Posts

EXEL   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  22230 of 22751  at  6/19/2019 11:39:30 AM  by

wilderguide


Re: First- and second-line treatments for locally advanced renal cell carcinoma

"Different drugs involved but the idea to not look for biomarkers but rather adverse effects to judge the effectiveness of a treatment is, I think, a new idea that showed promise in this study."
Not truly a new idea, but one gaining in traction. Antiangiogenics have long been known to constrict the blood-carry vasculature, producing high blood pressure. The concept of gauging the effectiveness of antiangiogenic by monitoring blood pressure is as old as Avastin. Same same hand-foot syndrome...
They really need to be watchful of both biometrics and emerging (or diminishing) AEs. I suspect the underlying biology will someday reflect the two are closely intertwined.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 3     Views: 269
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...